Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07867899

Dexmedetomidine for Prevention of Delirium After Hip Fracture Surgery

Conditions: Delirium - Postoperative, Delirium Prevention, Dexmedetomidine, Dexmedetomidine Infusion

Sex: All
Ages: 65 Years – N/A
Healthy volunteers: No
Enrollment: 242
Sponsor: Peter Gaarsdal Uhrbrand

Location: Department of Anesthesiology, Aarhus University Hospital Aarhus

Summary

Postoperative delirium is common after hip fracture surgery and is associated with delayed recovery and serious postoperative complications. Patients with hip fracture are often elderly, acutely admitted, in pain, and have multiple comorbidities, all of which increase the risk of delirium. This study evaluates whether implementation of intraoperative dexmedetomidine prophylaxis reduces postoperative delirium in patients undergoing hip fracture surgery. The study will compare patients treated before and after implementation of dexmedetomidine prophylaxis.

Eligibility Criteria

Inclusion Criteria: * Patients at least 65 years of age undergoing surgery for hip fracture in general or spinal anesthesia * Treated during the defined pre- or post-implementation period Exclusion Criteria: * Known hypersensitivity to dexmedetomidine * Second- or third-degree AV block without pacemaker * Acute cerebral conditions with potentially impaired cerebral autoregulation * Acute or chronic liver failure

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07867899). StuddyBuddy aggregates publicly available trial information.